A Study of Vaccination With 9-valent Extraintestinal Pathogenic Escherichia Coli Vaccine (ExPEC9V) in the Prevention of Invasive Extraintestinal Pathogenic Escherichia Coli Disease in Adults Aged 60 Years And Older With a History of Urinary Tract Infection in the Past 2 Years
- Conditions
- Interventions
- First Posted Date
- 2021-05-24
- Last Posted Date
- 2024-12-10
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 18556
- Registration Number
- NCT04899336
- Locations
- π¬π§
Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom
π¬π§Plymouth University Hospitals Trust, Plymouth, United Kingdom
π©πͺUniversitatsklinikum Frankfurt, Frankfurt, Germany
A Study of JNJ-78278343, a T-Cell-Redirecting Agent Targeting Human Kallikrein 2 (KLK2), for Advanced Prostate Cancer
- First Posted Date
- 2021-05-24
- Last Posted Date
- 2024-12-06
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 260
- Registration Number
- NCT04898634
- Locations
- π¨π³
Chongqing University Cancer Hospital, Chongqing, China
π¨π³First Affiliated Hospital Of Wenzhou Medical College, Wen Zhou Shi, China
πΊπΈColumbia University Medical Center Herbert Irving Pavilion, New York, New York, United States
A Study of Nipocalimab in Adult Participants With Active Systemic Lupus Erythematosus
- Conditions
- Interventions
- First Posted Date
- 2021-05-12
- Last Posted Date
- 2024-12-06
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 228
- Registration Number
- NCT04882878
- Locations
- πΊπ¦
Medbud-Clinic LLC, Kyiv, Ukraine
π§π¬UMHAT St. Ivan Rilski, Sofia, Bulgaria
πΊπΈValerius Medical Group & Research Center, Los Alamitos, California, United States
A Study of Nipocalimab in Adult Participants With Active Lupus Nephritis
- Conditions
- Interventions
- First Posted Date
- 2021-05-12
- Last Posted Date
- 2024-12-06
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 80
- Registration Number
- NCT04883619
- Locations
- πΊπΈ
Omega Research Consultants, DeBary, Florida, United States
πΊπΈValerius Medical Group & Research Center, Los Alamitos, California, United States
πΊπΈRespire Research, LLC, Palm Springs, California, United States
A Study of Guselkumab in Participants With Active Psoriatic Arthritis
- First Posted Date
- 2021-05-11
- Last Posted Date
- 2024-12-05
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 950
- Registration Number
- NCT04882098
- Locations
- πΊπ¦
Komunalnyi zaklad Kryvorizka miska klinichna likarnia #2 Dnipropetrovskoi oblasnoi rady, Kryvyi Rih, Ukraine
πΊπ¦Khmelnitska oblasna likarnia, Khmelnitsky, Ukraine
πΊπ¦Derzhavna ustanova Natsionalnyi instytut terapii imeni L.T.Maloi NAMN Ukrainy viddil klinichnoi, Kharkiv, Ukraine
A Study of the MALT1 Inhibitor JNJ-67856633 and Ibrutinib in Combination in B-cell NHL and CLL
- Conditions
- Interventions
- First Posted Date
- 2021-05-06
- Last Posted Date
- 2024-12-06
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 45
- Registration Number
- NCT04876092
- Locations
- π«π·
Institut Paoli Calmettes, Marseille, France
π«π·Hopital St Louis, Paris, France
π©π°Rigshospitalet, Copenhagen, Denmark
A Study of JNJ-56136379 in Healthy Participants
- Conditions
- Interventions
- First Posted Date
- 2021-04-21
- Last Posted Date
- 2021-07-15
- Lead Sponsor
- Janssen Research & Development, LLC
- Registration Number
- NCT04853524
A Study of Nipocalimab in Healthy Male and Female Participants
- First Posted Date
- 2021-04-19
- Last Posted Date
- 2023-07-03
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 89
- Registration Number
- NCT04848558
- Locations
- π³π±
PRA Health Sciences, Groningen, Netherlands
A Study of JNJ-68179280 in Healthy Participants
- First Posted Date
- 2021-04-14
- Last Posted Date
- 2023-07-24
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 94
- Registration Number
- NCT04844463
- Locations
- πΊπΈ
Celerion, Lincoln, Nebraska, United States
A Study of JNJ-67835989 in Healthy Participants
- First Posted Date
- 2021-04-14
- Last Posted Date
- 2024-05-22
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 109
- Registration Number
- NCT04844411
- Locations
- π§πͺ
Clinical Pharmacology Unit, Merksem, Belgium